Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial
Titel:
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial
Auteur:
Agarwal, Neeraj Azad, Arun A Carles, Joan Matsubara, Nobuaki Oudard, Stéphane Saad, Fred Merseburger, Axel S Soares, Andrey McGregor, Bradley A Zurawski, Bogdan Tsiatas, Marinos North, Scott Bondarenko, Igor Alfie, Margarita Bournakis, Evangelos Antonuzzo, Lorenzo Evilevitch, Lena Simmons, Andrew Wang, Fong Ferraldeschi, Roberta Nandoskar, Prachi Pal, Sumanta K